Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022 / 12:30PM GMT
Unidentified Analyst
Hey, good morning, everyone, and welcome to Baird's Annual Healthcare Conference. I'm really pleased to be kicking off the conference with Novavax. And with me today, I have Gregory Glenn, President of R&D; and John Trizzino, Chief Commercial Officer and Chief Business Officer. Greg and John, thanks so much for joining us today.
John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer
Great to be here as well, thank you.
Questions & Answers
Unidentified Analyst
So to begin, could you provide an overview of Novavax? And I think most people here would probably be familiar with Novavax now but also kind of recent update on progress to date.
John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer
Yes. So maybe I'll just kind of kick things off with where we are with our activities since the beginning of the pandemic as it's been quite a venture, chatted a little bit briefly this
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot